RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis.
Strauss L, Sangaletti S, Consonni FM, Szebeni G, Morlacchi S, Totaro MG, Porta C, Anselmo A, Tartari S, Doni A, Zitelli F, Tripodo C, Colombo MP, Sica A.
Cancer Cell. 2015 Aug 10;28(2):253-69. doi: 10.1016/j.ccell.2015.07.006.

2015

miR-30e* is an independent subtype-specific prognostic marker in breast cancer.
D'Aiuto F, Callari M, Dugo M, Merlino G, Musella V, Miodini P, Paolini B, Cappelletti V,
Daidone MG.
Br J Cancer.
2015 Jul 14;113(2):290-8.
doi: 10.1038/bjc.2015.206.
Epub 2015 Jun 9.

2015

Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR.
Conte D, Verri C, Borzi C, Suatoni P, Pastorino U, Sozzi G,
Fortunato O.
BMC Genomics. 2015 Oct 23;16:849. doi: 10.1186/s12864-015-2097-9.

2015

Circulating Biomarkers for Prediction of Treatment Response.
Cappelletti V, Appierto V, Tiberio P, Fina E, Callari M, Daidone MG.
J Natl Cancer Inst Monogr. 2015 May;2015(51):60-3. doi: 10.1093/jncimonographs/lgv006.

2015

By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy
Petrelli A, Carollo R, Cargnelutti M, Iovino F, Callari M, Cimino D, Todaro M, Mangiapane LR, Giammona A, Cordova A, Montemurro F, Taverna D, Daidone MG, Stassi G, Giordano S.
Oncotarget. 2015 Feb 10;6(4):2315-30.

2015

Gene expression profiling of circulating tumor cells in breast cancer.
Fina E, Callari M, Reduzzi C, D'Aiuto F, Mariani G, Generali D, Pierotti MA, Daidone MG, Cappelletti V.
Clin Chem. 2015 Jan;61(1):278-89. doi: 10.1373/clinchem.2014.229476.
Epub 2014 Nov 19.

2015

Targeting microRNAs to withstand cancer metastasis.
Profumo V, Doldi V, Gandellini P, Zaffaroni N.
Methods Mol Biol. 2015;1218:415-37. doi: 10.1007/978-1-4939-1538-5_25.

2015

Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation.
Landoni E, Miceli R, Callari M, Tiberio P, Appierto V, Angeloni V, Mariani L, Daidone MG.
BMC Bioinformatics. 2015 Nov 18;16:388. doi: 10.1186/s12859-015-0820-9.

2015

Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation.
Doldi V, Callari M, Giannoni E, D'Aiuto F, Maffezzini M, Valdagni R, Chiarugi P, Gandellini P, Zaffaroni N
Oncotarget. 2015 Oct 13;6(31):31441-60. doi: 10.18632/oncotarget.5056.

2015

Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression.
Giussani M, Merlino G, Cappelletti V, Tagliabue E, Daidone MG
Semin Cancer Biol. 2015 Dec;35:3-10. doi: 10.1016/j.semcancer.2015.09.012. Epub 2015 Sep 28.

2015

Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types.
Gandellini P, Andriani F, Merlino G, D'Aiuto F, Roz L, Callari M
Semin Cancer Biol. 2015 Dec;35:96-106. doi: 10.1016/j.semcancer.2015.08.008.
Epub 2015 Aug 28

2015

Germline polymorphisms and survival of lung adenocarcinoma patients: A genome-wide study in two European patient series.
Galvan A, Colombo F, Frullanti E, Dassano A, Noci S, Wang Y, Eisen T, Matakidou A, Tomasello L, Vezzalini M, Sorio C, Dugo M, Ambrogi F, Iacobucci I, Martinelli G, Incarbone M, Alloisio M, Nosotti M, Tosi D, Santambrogio L, Pelosi G, Pastorino U, Houlston RS, Dragani TA
Int J Cancer.
2015 Mar 1;136(5):E262-71.
doi: 10.1002/ijc.29195.
Epub 2014 Sep 19

2015

The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-ß Responsive Colon Carcinoma.
Sokolova V, Fiorino A, Zoni E, Crippa E, Reid JF, Gariboldi M, Pierotti MA
J Cell Physiol. 2015 Dec;230(12):3105-14. doi: 10.1002/jcp.25051

2015

Moving from discovery to validation in circulating microRNA research.
Verderio P, Bottelli S, Ciniselli CM, Pierotti MA, Zanutto S, Gariboldi M, Pizzamiglio S
Int J Biol Markers. 2015 May 26;30(2):e258-61. doi: 10.5301/jbm.5000135.

2015

SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias.
Vitali C, Bassani C, Chiodoni C, Fellini E, Guarnotta C, Miotti S, Sangaletti S, Fuligni F, De Cecco L, Piccaluga PP, Colombo MP, Tripodo C
Cancer Res. 2015 Jun 1;75(11):2387-99. doi: 10.1158/0008-5472.CAN-14-3625. Epub 2015 Apr 9.

2015

Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells.
De Cecco L, Capaia M, Zupo S, Cutrona G, Matis S, Brizzolara A, Orengo AM, Croce M, Marchesi E, Ferrarini M, Canevari S, Ferrini S
PLoS One. 2015 Aug 25;10(8):e0134706. doi: 10.1371/journal.pone.0134706.
eCollection 2015.

2015

Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.
Boeri M, Sestini S, Fortunato O, Verri C, Suatoni P, Pastorino U, Sozzi G
Expert Rev Mol Diagn. 2015 Jun;15(6):801-13. doi: 10.1586/14737159.2015.1041377. Epub 2015 Apr 30.

2015

Microenvironment modulated
metastatic CD133+/CXCR4+/
EpCAM- lung cancer initiating
cells sustain tumor dissemination
and correlate with poor prognosis.
Bertolini G, D'Amico L, Moro M, Landoni E, Perego P, Miceli R, Gatti L, Andriani F, Wong D, Caserini R, Tortoreto M,
Milione M, Ferracini R,
Mariani L, Pastorino U, Roato I, Sozzi G, Roz L
Cancer Res. 2015 Sep 1;75(17):3636-49. doi: 10.1158/0008-5472.CAN-14-3781. Epub 2015 Jul 3.

2015

Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations.
Hu J, Boeri M, Sozzi G, Liu D, Marchianò A, Roz L, Pelosi G, Gatter K, Pastorino U, Pezzella F
EBioMedicine. 2015 Jul 8;2(8):831-40. doi: 10.1016/j.ebiom.2015.07.001. eCollection 2015 Aug.

2015

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Sestini S, Boeri M, Marchiano A, Pelosi G, Galeone C, Verri C, Suatoni P, Sverzellati N, La Vecchia C, Sozzi G, Pastorino U
Oncotarget. 2015 Oct 20;6(32):32868-77. doi: 10.18632/oncotarget.5210.

2015

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié

Progetto finanziato con

il contributo Airc 5x1000

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié